ESVAL KEVIN JAMES enters PANACEA LIFE SCIENCES HOLDINGS, INC. with 3.40M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 1/17/2019ACC: 0001415889-19-000081
Director
Since Jan 2019
3.40M
Baseline shares
0% direct
2K
Direct ownership
1 position
2.17M
Derivative underlying
2 instruments
2
Security positions
3.40M indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned2K
Common Stock
IndirectShares owned3.40M
Total
2K direct·3.40M indirect3.40M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Direct |
| Common Stock | 3.40M | Indirect |
| Total | 3.40M | 2K direct·3.40M indirect |
Derivative Holdings2
Options to purchase common stock
DirectUnderlying security
Common Stock
Underlying shares
2M
Shares owned
N/A
Exercise price
0.025
Expiration
—
Exercise window
—
Series B-2 Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
168K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
2.17M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to purchase common stock Direct | Common Stock | 0.025 | — | — | 2M | N/A |
| Series B-2 Preferred Stock Indirect | Common Stock | 0 | — | — | 168K | N/A |
| Total | 2.17M | 0.00 | ||||